Abstract submission deadline is the 09 April, 2023

Symposiums deadline is the 30 March, 2023

    Title, Type and Topic

    Please enter the title of your abstract, and select the type and the topic.

    Authors *

    Presenting author

    Co-authors’ details

    Title, Type and Topic

    Abstract submission guidelines
    Please read the Abstract submission guidelines below and confirm.
    Please read the submission rules before submitting an abstract.

    • Abstracts must be submitted online via the website only.

    • Presentation Type: Abstracts may be submitted for Oral or Poster or Online Publication.

    • All oral presentations must be IN PERSON at the Yerevan, Armenia location.

    • Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.

    • Previous Publications of an Abstract – the work must not have been previously accepted by or published in a peer-reviewed journal at the time of abstract submission.

    • Previous Presentation of an Abstract – the work must not have been previously presented at a meeting of any other scientific organization.


    • Clinical Trials in Progress Abstracts can be submitted.

    • Shell Abstracts (abstracts that provide no data) cannot be submitted.
      A shell abstract is one that intends to have data but the data are either not collected yet or analysed yet. Qualitative data are appropriate to submit.

    • The same person may submit up to 5 abstracts regardless of the presenting author.

    • The same person may serve as presenting author on up to 5 abstracts.

    • Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by the date indicated in the notification email will be scheduled for presentation.

    • Submission of an abstract acknowledges your acceptance for the abstract to be published.

    • The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.

    • Abstracts must be submitted in English.
      All abstracts should be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication.

    • Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interest in the submission form.

    Before you begin, please prepare the following information:

    • Presenting author’s contact details:
      – Full first and family name(s)
      – Email address
      – Affiliation details: department, institution/hospital, city-state (if relevant), Country
      – Phone number

    • Author and co-authors’ details

    • Preferred Presentation type: Oral Presentation/Poster

    • Abstract title – must be in UPPER CASE and limited to 25 words. Symbols should not be considered as words

    • Abstract text – limited to 400 words including acknowledgements.

    • Abstract topic – select the abstract topic per the list of topics.

    • Text only is to be submitted. Tables, figures and bulleted text are not permitted.

    • Abstracts should clearly state Background and aims, Methods, Results, and Conclusions

    • Please use as few abbreviations as possible and only commonly used abbreviations.

    • Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.

    • Submissions may not contain patient names, hospital ID numbers or other identifying information.

    • Periods should be used in numbers for decimal points, not commas, i.e. P=0.015

    • All measurements must be in metric units.

    • Abstracts stating “data will be discussed in the presentation” will NOT be accepted.

    • Please do not submit multiple copies of the same abstract.

    During the abstract submission process, you will be requested to confirm your agreement to the following:

    • I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published as submitted.

    • Submission of the abstract constitutes the consent of all authors to publication (e.g. Congress website, programs, other promotions, etc.)

    • The Abstract Submitter grants the Organizers a copyright licence to reproduce, publish, translate, distribute, and display the text of the Content on a royalty-free, perpetual, irrevocable nonexclusive basis.

    • I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on the abstract correspondence.

    • I understand that the presenting author must be a registered participant.

    • The Organizers reserve the right to remove from publication and/or presentation an abstract which does not comply with the above.

    • I understand that I must select a specific Theme, Topic and/or Sub-Topic for my abstract allocation. Although the Committee will work hard to honour this selection, this cannot be guaranteed. The Committee reserves the right to change the Theme, Topic or Sub-Topic under which the abstract was originally submitted.

    All abstracts will be evaluated anonymously and scored by the appropriate Scientific Programme Advisory Committee members. The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
    The Scientific Committee will determine If accepted as:

    • an oral presentation;

    • a poster presentation, possibly with a poster session participation or special Scientific Committee mention;

    • a journal publication